This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: James C Haber, Jr: Innovator in Polycyclic Guanine Derivatives
Introduction
James C Haber, Jr. is a notable inventor based in Scotia, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on polycyclic guanine derivatives. His innovative approach aims to address pain and inflammatory diseases, showcasing his commitment to improving healthcare.
Latest Patents
Haber holds a patent for "Polycyclic Guanine Derivatives and Use Thereof." This invention relates to polycyclic guanine derivatives, compositions that include these derivatives, and methods for utilizing them to treat pain or inflammatory diseases. His work in this area has the potential to lead to new therapeutic options for patients suffering from these conditions. He has 1 patent to his name.
Career Highlights
James C Haber, Jr. is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation.
Collaborations
Some of his notable coworkers include Deen Tulshian and William Bert Geiss. Their collaborative efforts have likely played a role in advancing the research and development of new therapeutic solutions.
Conclusion
James C Haber, Jr. exemplifies the spirit of innovation in the pharmaceutical industry through his work on polycyclic guanine derivatives. His contributions not only reflect his expertise but also his dedication to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile